Myristoyllevocarnitine
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597645

CAS#: 25597-07-3

Description: Myristoyllevocarnitine is a human carnitine involved in beta-oxidation of long-chain fatty acids.


Chemical Structure

img
Myristoyllevocarnitine
CAS# 25597-07-3

Theoretical Analysis

MedKoo Cat#: 597645
Name: Myristoyllevocarnitine
CAS#: 25597-07-3
Chemical Formula: C21H41NO4
Exact Mass: 371.3036
Molecular Weight: 371.56
Elemental Analysis: C, 67.88; H, 11.12; N, 3.77; O, 17.22

Price and Availability

Size Price Availability Quantity
10.0mg USD 250.0 2 Weeks
50.0mg USD 550.0 2 Weeks
Bulk inquiry

Synonym: Myristoyllevocarnitine; (-)-Myristoylcarnitine; (R)-Tetradecanoylcarnitine; Myristoyl-L-carnitine;

IUPAC/Chemical Name: (R)-3-(tetradecanoyloxy)-4-(trimethylammonio)butanoate

InChi Key: PSHXNVGSVNEJBD-LJQANCHMSA-N

InChi Code: InChI=1S/C21H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h19H,5-18H2,1-4H3/t19-/m1/s1

SMILES Code: CCCCCCCCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 371.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Cristofano A, Sapere N, La Marca G, Angiolillo A, Vitale M, Corbi G, Scapagnini G, Intrieri M, Russo C, Corso G, Di Costanzo A. Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia. PLoS One. 2016 May 19;11(5):e0155694. doi: 10.1371/journal.pone.0155694. eCollection 2016. PubMed PMID: 27196316; PubMed Central PMCID: PMC4873244.

2: Kamimori H, Hamashima Y, Konishi M. Determination of carnitine and saturated-acyl group carnitines in human urine by high-performance liquid chromatography with fluorescence detection. Anal Biochem. 1994 May 1;218(2):417-24. PubMed PMID: 8074302.

3: Ho JK, Duclos RI Jr, Hamilton JA. Interactions of acyl carnitines with model membranes: a (13)C-NMR study. J Lipid Res. 2002 Sep;43(9):1429-39. PubMed PMID: 12235174.

4: Ummenhofer WC, Bernards CM. Acylcarnitine chain length influences carnitine-enhanced drug flux through the spinal meninges in vitro. Anesthesiology. 1997 Mar;86(3):642-8. PubMed PMID: 9066331.

5: Sabbagh E, Cuebas D, Schulz H. 3-Mercaptopropionic acid, a potent inhibitor of fatty acid oxidation in rat heart mitochondria. J Biol Chem. 1985 Jun 25;260(12):7337-42. PubMed PMID: 3997873.

6: Bene J, Komlósi K, Havasi V, Talián G, Gasztonyi B, Horváth K, Mózsik G, Hunyady B, Melegh B, Figler M. Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis. World J Gastroenterol. 2006 Jan 7;12(1):110-3. PubMed PMID: 16440427; PubMed Central PMCID: PMC4077497.

7: Chase JF. The substrate specificity of carnitine acetyltransferase. Biochem J. 1967 Aug;104(2):510-8. PubMed PMID: 6069132; PubMed Central PMCID: PMC1270613.

8: Minkler PE, Kerner J, North KN, Hoppel CL. Quantitation of long-chain acylcarnitines by HPLC/fluorescence detection: application to plasma and tissue specimens from patients with carnitine palmitoyltransferase-II deficiency. Clin Chim Acta. 2005 Feb;352(1-2):81-92. PubMed PMID: 15653102.

9: Fritz IB, Burdzy K. Novel action of carnitine: inhibition of aggregation of dispersed cells elicited by clusterin in vitro. J Cell Physiol. 1989 Jul;140(1):18-28. PubMed PMID: 2472418.

10: Lohninger A, Krieglsteiner HP, Salzer H, Vytiska-Binstorfer E, Riedl W, Erhardt W. Studies on the effects of betamethasone, L-carnitine, and betamethasone-L-carnitine combinations on the dipalmitoyl phosphatidylcholine content and phosphatidylcholine species composition in foetal rat lungs. J Clin Chem Clin Biochem. 1986 Jun;24(6):361-8. PubMed PMID: 3755749.

11: Fontaine M, Briand G, Largillière C, Degand P, Divry P, Vianey-Saban C, Mousson B, Vamecq J. Metabolic studies in a patient with severe carnitine palmitoyltransferase type II deficiency. Clin Chim Acta. 1998 May 25;273(2):161-70. PubMed PMID: 9657346.

12: Kashfi K, Mynatt RL, Park EA, Cook GA. Membrane microenvironment regulation of carnitine palmitoyltranferases I and II. Biochem Soc Trans. 2011 Jun;39(3):833-7. doi: 10.1042/BST0390833. PubMed PMID: 21599656.

13: Haeyaert P, Verdonck A, Van Cauwelaert FH. Influence of acylcarnitines of different chain length on pure and mixed phospholipid vesicles and on sarcoplasmic reticulum vesicles. Chem Phys Lipids. 1987 Oct;45(1):49-63. PubMed PMID: 2965625.

14: Fujiwara A, Fujisaki H, Asai H, Yasumasu I. Inhibition of palmitoyl CoA of EDTA- and Mg2+-ATPase of heavy meromyosin from rabbit skeletal muscle. J Biochem. 1981 Sep;90(3):757-63. PubMed PMID: 6118360.

15: Broadway NM, Saggerson ED. Effect of membrane environment on the activity and inhibitability by malonyl-CoA of the carnitine acyltransferase of hepatic microsomal membranes. Biochem J. 1997 Mar 1;322 ( Pt 2):435-40. PubMed PMID: 9065760; PubMed Central PMCID: PMC1218209.

16: Yamamoto T. Rat liver peroxisomal and mitochondrial fatty acid oxidation in sepsis. Surg Today. 1993;23(2):137-43. PubMed PMID: 8467159.

17: Yokokawa M, Fujiwara A, Shimada H, Yasumasu I. Inhibitory effect of long chain fatty acyl CoAs on RNA polymerase from Escherichia coli. J Biochem. 1983 Aug;94(2):415-20. PubMed PMID: 6355076.

18: Shinagawa S, Kanamaru T, Harada S, Asai M, Okazaki H. Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues. J Med Chem. 1987 Aug;30(8):1458-63. PubMed PMID: 3612690.

19: Ramsay RR, Derrick JP, Friend AS, Tubbs PK. Purification and properties of the soluble carnitine palmitoyltransferase from bovine liver mitochondria. Biochem J. 1987 Jun 1;244(2):271-8. PubMed PMID: 3663121; PubMed Central PMCID: PMC1147987.

20: Cordente AG, López-Viñas E, Vázquez MI, Swiegers JH, Pretorius IS, Gómez-Puertas P, Hegardt FG, Asins G, Serra D. Redesign of carnitine acetyltransferase specificity by protein engineering. J Biol Chem. 2004 Aug 6;279(32):33899-908. Epub 2004 May 21. PubMed PMID: 15155769.